688656.SS SHH
HOB Biotech Group Corp.,Ltd
1W: +12.1%
1M: +36.6%
3M: +26.6%
YTD: -7.5%
1Y: +17.7%
3Y: +288.9%
5Y: +71.8%
¥131.72 ($19.64)
-0.31 (-0.23%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$398M
-1.0% ▼
5Y CAGR: +12.4%
Gross Profit
$233M
-9.5% ▼
5Y CAGR: +9.9%
Operating Income
$27M
-35.2% ▼
5Y CAGR: -16.2%
Net Income
$23M
-37.0% ▼
5Y CAGR: -16.3%
EPS (Diluted)
$0.37
-36.2% ▼
5Y CAGR: -21.0%
EBITDA
$64M
-23.3% ▼
5Y CAGR: -0.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $318M | $320M | $394M | $402M | $398M |
| YoY Growth | +43.2% | +0.8% | +23.1% | +2.0% | -1.0% |
| Cost of Revenue | $99M | $118M | $149M | $145M | $166M |
| Gross Profit | $219M | $202M | $245M | $257M | $233M |
| Gross Margin | 69.0% | 63.1% | 62.1% | 63.9% | 58.4% |
| R&D Expenses | $32M | $39M | $47M | $46M | $0 |
| SG&A Expenses | $99M | $117M | $139M | $159M | $45M |
| Operating Expenses | $122M | $155M | $189M | $216M | $206M |
| Operating Income | $98M | $48M | $56M | $41M | $27M |
| Operating Margin | 30.7% | 14.8% | 14.2% | 10.3% | 6.7% |
| Interest Expense | $1M | $2M | $3M | $3M | $2M |
| Income Before Tax | $99M | $46M | $57M | $41M | $25M |
| Tax Expense | $13M | $5M | $9M | $4M | $2M |
| Net Income | $86M | $42M | $47M | $37M | $23M |
| Net Margin | 27.1% | 13.0% | 12.0% | 9.1% | 5.8% |
| EPS (Diluted) | $1.40 | $0.66 | $0.74 | $0.58 | $0.37 |
| EBITDA | $104M | $69M | $86M | $83M | $64M |
| Shares Outstanding | 63M | 63M | 64M | 63M | 63M |